EP4021433 - TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 01.09.2023 Database last updated on 10.07.2024 | |
Former | Grant of patent is intended Status updated on 10.04.2023 | ||
Former | Request for examination was made Status updated on 03.06.2022 | ||
Former | The international publication has been made Status updated on 05.03.2021 | ||
Former | unknown Status updated on 25.09.2020 | Most recent event Tooltip | 24.05.2024 | Lapse of the patent in a contracting state | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states Period Pill BV Nes 116 1012 KE Amsterdam / NL | [2022/27] | Inventor(s) | 01 /
JANSSEN, Merel Rijksstraatweg 163 1396 JK Baambrugge / NL | 02 /
JANSSEN, Edgar Stijn Jochem Rijksstraatweg 163 1396 JK Baambrugge / NL | 03 /
GOLAN, Ezekiel 1120 Ironwork Passage, False Creek Vancouver, British Columbia V6H 3P1 / CA | [2022/27] | Representative(s) | Michalski Hüttermann & Partner Patentanwälte mbB Kaistraße 16A 40221 Düsseldorf / DE | [2022/27] | Application number, filing date | 20772102.8 | 26.08.2020 | [2022/27] | WO2020IB57967 | Priority number, date | US201962891438P | 26.08.2019 Original published format: US 201962891438 P | [2022/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021038460 | Date: | 04.03.2021 | Language: | EN | [2021/09] | Type: | A1 Application with search report | No.: | EP4021433 | Date: | 06.07.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.03.2021 takes the place of the publication of the European patent application. | [2022/27] | Type: | B1 Patent specification | No.: | EP4021433 | Date: | 04.10.2023 | Language: | EN | [2023/40] | Search report(s) | International search report - published on: | EP | 04.03.2021 | Classification | IPC: | A61K31/137, A61P15/00, A61P25/00 | [2022/27] | CPC: |
A61K31/137 (EP,CN,IL,KR,US);
A61P15/00 (EP,CN,IL,US);
A61P15/02 (KR);
A61P25/00 (EP,CN,IL,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/27]
![]() | Extension states | BA | 24.03.2022 | ME | 24.03.2022 | Validation states | MA | 24.03.2022 | Title | German: | BEHANDLUNG VON MENSTRUATIONSZYKLUSINDUZIERTEN SYMPTOMEN | [2022/27] | English: | TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMS | [2022/27] | French: | TRAITEMENT DE SYMPTÔMES INDUITS PAR LE CYCLE MENSTRUEL | [2022/27] | Entry into regional phase | 24.03.2022 | National basic fee paid | 24.03.2022 | Designation fee(s) paid | 24.03.2022 | Examination fee paid | Examination procedure | 24.03.2022 | Amendment by applicant (claims and/or description) | 24.03.2022 | Examination requested [2022/27] | 24.03.2022 | Date on which the examining division has become responsible | 11.04.2023 | Communication of intention to grant the patent | 21.08.2023 | Fee for grant paid | 21.08.2023 | Fee for publishing/printing paid | 21.08.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 25.08.2022 | Renewal fee patent year 03 | 25.08.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | RS | 04.10.2023 | [2024/26] | Cited in | International search | [A]WO2005049088 (NOVARTIS AG [CH], et al) [A] 1-35 * the whole document * * page 18, paragraph 2; claim 6 *; | [A]WO2013171146 (LOHMANN THERAPIE SYST LTS [DE]) [A] 1-35 * the whole document ** claims 6,31 *; | [AD]WO2019026019 (THERAPEUTIC ADJUNCTS INC [CA], et al) [AD] 1-35 * the whole document * * claims 1-19 * | by applicant | US2004048919 | US2004127409 | US2006241172 | US2006241176 | US2007098819 | US2007203078 | US2007255278 | US2008160083 | US2008262071 | US2010172916 | US2011207718 | US2013171269 | US2014356424 | US2016000815 | US2016058428 | US2016367614 | WO2019026019 | US2019099399 | - SCHOEP et al., Am J Obs Gyn, (20190000), vol. 220, page 569 | - DANFORTH et al., Prog Neuro-Psych and Biol Psych, (20160000), vol. 64, pages 237 - 249 | - AMOROSO et al., J. Psychopharm, (20160000), vol. 30, pages 595 - 600 | - FINGL et al., The Pharmacological Basis of Therapeutics, Mack Publishing Co., (19750000), page 1 |